0914 ET - Church & Dwight's stock has underperformed its peers over the past year, but Raymond James analysts say they don't expect that to be the case much longer. Given the consumer-goods company's defensive portfolio and depressed valuation relative to rivals, the analysts say in a research note that they expect shares to outperform in 2026. The maker of Arm & Hammer and OxiClean has had solid sales and earnings as of late, and its value-skewed portfolio positions it well across a range of macro outcomes, the analysts say. At the same time, Church & Dwight has been disciplined in M&A in recent years, they add, and the company stands to benefit from divesting its vitamin business. Raymond James upgrades Church & Dwight to outperform from market perform. (connor.hart@wsj.com)
(END) Dow Jones Newswires
January 05, 2026 09:14 ET (14:14 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments